SCHEMBL23840293

SCHEMBL23840293

CC(C)(C)c1cc(-n2c(C(C)(C)C)nc3ccccc32)c(Cl)c(-n2c(C(C)(C)C)nc3ccccc32)c1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 1/20 0.40
SMN1; SMN2 Q16637 4/20 0.39
MAPK1 P28482 2/20 0.38
TSHR P16473 1/20 0.38
CNR2 P34972 2/20 0.38
TP53 P04637 1/20 0.38
SLC22A12 Q96S37 2/20 0.37
NOS2 P35228 1/20 0.37
POLB P06746 1/20 0.37
HTT P42858 1/20 0.36
CYP2C9 P11712 1/20 0.36
GAA P10253 1/20 0.35
MAPT P10636 1/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
ACSS2 Q9NR19 1/20 0.34
HSD11B1 P28845 1/20 0.34
ALOX5AP P20292 1/20 0.34
ALOX15 P16050 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22600096 0.83 CNR2 (0.38) ADORA2ASMN1; SMN2MAPK1TSHRCNR2
SCHEMBL22600025 0.78 TSHR (0.39) ADORA2ASMN1; SMN2MAPK1TSHRCNR2
SCHEMBL24179382 0.76 ADORA2A (0.39) ADORA2ASMN1; SMN2MAPK1TSHRCNR2
SCHEMBL14124486 0.76 TSHR (0.45) ADORA2ASMN1; SMN2MAPK1TSHRCNR2
SCHEMBL14124469 0.76 TSHR (0.45) ADORA2ASMN1; SMN2MAPK1TSHRCNR2
SCHEMBL10041258 0.74 MAPK1 (0.49) ADORA2ASMN1; SMN2MAPK1TSHRCNR2
SCHEMBL10041280 0.74 MAPK1 (0.41) ADORA2ASMN1; SMN2MAPK1TSHRTP53
SCHEMBL25878270 0.74 CNR2 (0.54) SMN1; SMN2MAPK1TSHRCNR2TP53
SCHEMBL12026134 0.73 MAPK1 (0.61) SMN1; SMN2MAPK1TSHRCNR2SLC22A12
SCHEMBL10041277 0.72 MAPK1 (0.48) ADORA2AMAPK1TSHRCNR2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230157170-A1 HETEROAROMATIC COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES UDC IRELAND LIMITED (IE) 2023-05-18 US disclosed
US-20230157170-A1 HETEROAROMATIC COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES UDC IRELAND LIMITED (IE) 2023-05-18 US disclosed
WO-2021185712-A1 HETEROAROMATIC COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2021-09-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230157170-A1 HETEROAROMATIC COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES DDT, CTCF, EED ADORA2A 2953/4885SMN1; SMN2 4714/4885MAPK1 3866/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.